These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22766273)

  • 1. Microparticles and infectious diseases.
    Delabranche X; Berger A; Boisramé-Helms J; Meziani F
    Med Mal Infect; 2012 Aug; 42(8):335-43. PubMed ID: 22766273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-derived microparticles: a new challenge in neuroscience.
    Doeuvre L; Plawinski L; Toti F; Anglés-Cano E
    J Neurochem; 2009 Jul; 110(2):457-68. PubMed ID: 19457085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression.
    Øvstebø R; Aass HC; Haug KB; Trøseid AM; Gopinathan U; Kierulf P; Berg JP; Brandtzaeg P; Henriksson CE
    Innate Immun; 2012 Aug; 18(4):580-91. PubMed ID: 22180561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles.
    Oehmcke S; Mörgelin M; Malmström J; Linder A; Chew M; Thorlacius H; Herwald H
    Cell Microbiol; 2012 Jan; 14(1):107-19. PubMed ID: 21951918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury.
    Morel N; Morel O; Petit L; Hugel B; Cochard JF; Freyssinet JM; Sztark F; Dabadie P
    J Trauma; 2008 Mar; 64(3):698-704. PubMed ID: 18332810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria meningitidis-exposed whole blood.
    Øvstebø R; Hellum M; Aass HC; Trøseid AM; Brandtzaeg P; Mollnes TE; Henriksson CE
    Innate Immun; 2014 Jul; 20(5):552-60. PubMed ID: 24051102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane microparticles and diseases.
    Wu ZH; Ji CL; Li H; Qiu GX; Gao CJ; Weng XS
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2420-7. PubMed ID: 24089218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats.
    Mortaza S; Martinez MC; Baron-Menguy C; Burban M; de la Bourdonnaye M; Fizanne L; Pierrot M; Calès P; Henrion D; Andriantsitohaina R; Mercat A; Asfar P; Meziani F
    Crit Care Med; 2009 Jun; 37(6):2045-50. PubMed ID: 19384196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of microparticles in DIC and its impact on inflammatory processes.
    Rahman S; Cichon M; Hoppensteadt D; Cunanan J; Jeske W; Thethi I; Fareed J
    Clin Appl Thromb Hemost; 2011; 17(6):E202-4. PubMed ID: 21422058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procoagulant microparticles: disrupting the vascular homeostasis equation?
    Morel O; Toti F; Hugel B; Bakouboula B; Camoin-Jau L; Dignat-George F; Freyssinet JM
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2594-604. PubMed ID: 16990554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticles and type 2 diabetes.
    Leroyer AS; Tedgui A; Boulanger CM
    Diabetes Metab; 2008 Feb; 34 Suppl 1():S27-32. PubMed ID: 18358424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
    Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
    Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of microparticles in diabetic vascular complications.
    Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
    Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microparticles in atherothrombosis.
    Leroyer AS; Tedgui A; Boulanger CM
    J Intern Med; 2008 May; 263(5):528-37. PubMed ID: 18410596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.
    Morel O; Morel N; Jesel L; Freyssinet JM; Toti F
    Semin Immunopathol; 2011 Sep; 33(5):469-86. PubMed ID: 21866419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating endothelial microparticles: a new marker of vascular injury].
    Boulanger CM; Leroyer AS; Amabile N; Tedgui A
    Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):149-54. PubMed ID: 18579117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tissue factor-exposing microparticles.
    Lechner D; Weltermann A
    Thromb Res; 2008; 122 Suppl 1():S47-54. PubMed ID: 18691500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.